摘要
肺动脉高压是恶性的肺血管疾病,其病理生理学的改变过程机制十分复杂。临床上缺乏有效的药物治疗,病死率高,患者的身心健康遭受了极大的损害。虽然单靶点药物的合用能够有效缓解肺动脉高压患者的临床症状,但无法从根本上控制病程的进展。在经济上的难以负担,使绝大多数患者中途停止治疗,不利于疾病的诊治。中医药因其特有的作用,可以更好的服务于患者,减轻负担,使其更好的接受治疗。文章旨在梳理近年来中医药防治肺动脉高压的研究进展,以期为肺动脉高压的创新药物研发和临床治疗提供有益的参考。
Pulmonary arterial hypertension is a malignant pulmonary vascular disease with complex pathophysiological processes and mechanisms.Patients suffered great damage of physical and mental health because of clinical lack of effective drug treatment and high case fatality rate.Although the combination of single target drugs can effectively relieve the clinical symptoms of patients with pulmonary arterial hypertension,it cannot fundamentally control the progression of the disease.In the economic burden,the vast majority of patients stop treatment,which is not conducive to the diagnosis and treatment of the disease.Traditional Chinese medicine,due to its unique role,can better serve patients,reduce the burden,so that they can better receive treatment.This paper aimed to review the research progress of TCM prevention and treatment of pulmonary hypertension in recent years,in order to provide useful reference for innovative drug development and clinical treatment of pulmonary hypertension.
作者
侯文文
曲妮妮
HOU Wenwen;QU Nini(Liaoning University of Traditional Chinese Medicine,Shenyang 110847,Liaoning,China;Traditional Chinese Medicine Affiliated Hospital of Liaoning University of Traditional Chinese Medicine,Shenyang 110032,Liaoning,China)
出处
《实用中医内科杂志》
2022年第2期129-131,共3页
Journal of Practical Traditional Chinese Internal Medicine
基金
沈阳市重大科技创新研发计划(19-112-4-075)。
关键词
肺动脉高压
中医药
肺胀
胸痹
喘证
pulmonary arterial hypertension
traditional Chinese medicine
lung distension
chest obstruction
asthma syndrome
